Merck Seeks Stop Of Royalty Payments For Diabetes Patents
Merck Sharp & Dohme Corp. on Friday asked a Delaware federal judge to either invalidate or find it no longer needs to pay royalties on 10 patents related to its Januvia...To view the full article, register now.
Already a subscriber? Click here to view full article